{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T02:36:15Z","timestamp":1787452575172,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018940","name":"Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards Research","doi-asserted-by":"publisher","award":["MUST-SKL-2021-008"],"award-info":[{"award-number":["MUST-SKL-2021-008"]}],"id":[{"id":"10.13039\/100018940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373874"],"award-info":[{"award-number":["82373874"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173825"],"award-info":[{"award-number":["82173825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.phymed.2024.155688","type":"journal-article","created":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T00:37:44Z","timestamp":1714264664000},"page":"155688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor"],"prefix":"10.1016","volume":"129","author":[{"given":"Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehuang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruopeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7025-3690","authenticated-orcid":false,"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2668-3044","authenticated-orcid":false,"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"374","key":"10.1016\/j.phymed.2024.155688_bib0001","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai9338","article-title":"RON kinase: a target for treatment of cancer-induced bone destruction and osteoporosis","volume":"9","author":"Andrade","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phymed.2024.155688_bib0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.phymed.2024.155688_bib0003","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.phymed.2024.155688_bib0004","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway","volume":"65","author":"Bendre","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155688_bib0005","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14728222.2012.710200","article-title":"Ron receptor tyrosine kinase signaling as a therapeutic target","volume":"16","author":"Benight","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.phymed.2024.155688_bib0006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/14728222.2011.546351","article-title":"Therapeutic targeting of osteoclast function and pathways","volume":"15","author":"Broadhead","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.phymed.2024.155688_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104981","article-title":"Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis","volume":"159","author":"Cao","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2024.155688_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14082037","article-title":"The MST1R\/RON tyrosine kinase in cancer: oncogenic functions and therapeutic strategies","volume":"14","author":"Cazes","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.phymed.2024.155688_bib0009","first-page":"24","article-title":"Bone metastasis: concise overview","volume":"32","author":"Chin","year":"2015","journal-title":"Fed. Pract."},{"key":"10.1016\/j.phymed.2024.155688_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153838","article-title":"Dendrobine attenuates osteoclast differentiation through modulating ROS\/NFATc1\/MMP9 pathway and prevents inflammatory bone destruction","volume":"96","author":"Deng","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2024.155688_bib0011","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.21.02647","article-title":"Use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer: ASCO-OH (CCO) guideline update","volume":"40","author":"Eisen","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2024.155688_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3830212","article-title":"Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis","volume":"2020","author":"Fang","year":"2020","journal-title":"Med. Inflamm"},{"key":"10.1016\/j.phymed.2024.155688_bib0013","doi-asserted-by":"crossref","first-page":"19074","DOI":"10.1038\/srep19074","article-title":"Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts","volume":"6","author":"Feng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2024.155688_bib0014","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41584-023-00935-3","article-title":"Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone","volume":"19","author":"Ferrari","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phymed.2024.155688_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108164","article-title":"Computational screening of potential anti-inflammatory leads from Jeevaneeya Rasayana plants targeting COX-2 and 5- LOX by molecular docking and dynamic simulation approaches","volume":"171","author":"Hemavathi","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.phymed.2024.155688_bib0016","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/s41388-023-02688-5","article-title":"RON-augmented cholesterol biosynthesis in breast cancer metastatic progression and recurrence","volume":"42","author":"Hunt","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155688_bib0017","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-020-05653-y","article-title":"MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients","volume":"181","author":"Hunt","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phymed.2024.155688_bib0018","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/14656566.2014.903925","article-title":"Pharmacotherapy of bone metastases in breast cancer patients\u2013an update","volume":"15","author":"Jacobs","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.phymed.2024.155688_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092073","article-title":"Osteoblast-osteoclast communication and bone homeostasis","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phymed.2024.155688_bib0020","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1002\/ctm2.368","article-title":"A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor","volume":"11","author":"Ko","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.phymed.2024.155688_bib0021","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/138945010792006825","article-title":"The macrophage stimulating protein\/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression","volume":"11","author":"Kretschmann","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.phymed.2024.155688_bib0022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10549-006-9438-y","article-title":"RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer","volume":"105","author":"Lau","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phymed.2024.155688_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155141","article-title":"Hexahydrocurcumin from Zingiberis rhizoma attenuates lipopolysaccharide-induced acute pneumonia through JAK1\/STAT3 signaling pathway","volume":"122","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2024.155688_bib0024","article-title":"Punicalin attenuates breast cancer-associated osteolysis by inhibiting the NF-\u03baB signaling pathway of osteoclasts","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155688_bib0025","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb7135","article-title":"Targeting actin-bundling protein L-plastin as an anabolic therapy for bone loss","volume":"6","author":"Li","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phymed.2024.155688_bib0026","doi-asserted-by":"crossref","first-page":"e13291","DOI":"10.1111\/cpr.13291","article-title":"Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK\/NF-\u03baB pathway","volume":"55","author":"Li","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.phymed.2024.155688_bib0027","first-page":"3607","article-title":"Downregulation of miR203 induces overexpression of PIK3CA and predicts poor prognosis of gastric cancer patients","volume":"9","author":"Liang","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.phymed.2024.155688_bib0028","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00198-023-06818-3","article-title":"Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan","volume":"34","author":"Liu","year":"2023","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.phymed.2024.155688_bib0029","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41388-020-01613-4","article-title":"Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases","volume":"40","author":"Liu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155688_bib0030","first-page":"22","article-title":"Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect","volume":"9","author":"Luo","year":"2022","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.phymed.2024.155688_bib0031","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191820","article-title":"Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth","volume":"217","author":"Ma","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phymed.2024.155688_bib0032","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/bph.14709","article-title":"Multiple actions of parathyroid hormone-related protein in breast cancer bone metastasis","volume":"178","author":"Martin","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155688_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105508","article-title":"Tyrosine kinase Src is a regulatory factor of bone homeostasis","volume":"23","author":"Matsubara","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2024.155688_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10070218","article-title":"The osteoclast in bone metastasis: player and target","volume":"10","author":"Maurizi","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.phymed.2024.155688_bib0035","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s12276-022-00835-8","article-title":"Crizotinib attenuates cancer metastasis by inhibiting TGF\u03b2 signaling in non-small cell lung cancer cells","volume":"54","author":"Park","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phymed.2024.155688_bib0036","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jot.2022.01.003","article-title":"Puerarin specifically disrupts osteoclast activation via blocking integrin-\u03b23 Pyk2\/Src\/Cbl signaling pathway","volume":"33","author":"Qiu","year":"2022","journal-title":"J. Orthop. Translat."},{"key":"10.1016\/j.phymed.2024.155688_bib0037","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2024.155688_bib0038","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2024.155688_bib0039","first-page":"3309","article-title":"Understanding bisphosphonates and osteonecrosis of the jaw: uses and risks","volume":"19","author":"Rosini","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.phymed.2024.155688_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.886305","article-title":"The osteoclast traces the route to bone tumors and metastases","volume":"10","author":"Russo","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.phymed.2024.155688_bib0041","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2024.155688_bib0042","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1158\/1541-7786.MCR-20-0060","article-title":"Prostate epithelial RON signaling promotes M2 macrophage activation to drive prostate tumor growth and progression","volume":"18","author":"Sullivan","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155688_bib0043","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2024.155688_bib0044","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-030-20301-6_7","article-title":"Bone metastasis of breast cancer","volume":"1152","author":"Tahara","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phymed.2024.155688_bib0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7555\/JBR.27.20130038","article-title":"Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addiction","volume":"27","author":"Wang","year":"2013","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.phymed.2024.155688_bib0046","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.intimp.2016.09.006","article-title":"Therapeutic potential of Oroxylin A in rheumatoid arthritis","volume":"40","author":"Wang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2024.155688_bib0047","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrendo.2016.91","article-title":"Physiological and pathophysiological bone turnover\u2014role of the immune system","volume":"12","author":"Weitzmann","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phymed.2024.155688_bib0048","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv360","article-title":"CAPG and GIPC1: breast cancer biomarkers for bone metastasis development and treatment","volume":"108","author":"Westbrook","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phymed.2024.155688_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114761","article-title":"Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation","volume":"193","author":"Xian","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155688_bib0050","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbrc.2007.11.106","article-title":"Functional grouping of osteoclast genes revealed through microarray analysis","volume":"366","author":"Yang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2024.155688_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110316","article-title":"Polyphyllin VII protects from breast cancer-induced osteolysis by suppressing osteoclastogenesis via c-Fos\/NFATc1 signaling","volume":"120","author":"Yang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2024.155688_bib0052","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.drudis.2020.05.012","article-title":"Antibody-drug conjugates targeting RON receptor tyrosine kinase as a novel strategy for treatment of triple-negative breast cancer","volume":"25","author":"Yao","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phymed.2024.155688_bib0053","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrc3545","article-title":"MSP-RON signalling in cancer: pathogenesis and therapeutic potential","volume":"13","author":"Yao","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2024.155688_bib0054","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.cr.7290266","article-title":"Mechanisms of cancer metastasis to the bone","volume":"15","author":"Yin","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.phymed.2024.155688_bib0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1142\/S0192415X23500155","article-title":"Mechanistic role of Scutellaria baicalensis Georgi in breast cancer therapy","volume":"51","author":"Yu","year":"2023","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.phymed.2024.155688_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155416","article-title":"Preparation and characterisation of baicalin magnesium and its protective effect in ulcerative colitis via gut microbiota-bile acid axis modulation","volume":"126","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2024.155688_bib0057","first-page":"651","article-title":"Prevention and treatment of osteoporosis caused by oestrogen shortage in rats","volume":"31","author":"Zhang","year":"2018","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.phymed.2024.155688_bib0058","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phrs.2019.02.015","article-title":"Sinomenine inhibits osteolysis in breast cancer by reducing IL-8\/CXCR1 and c-Fos\/NFATc1 signaling","volume":"142","author":"Zhang","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2024.155688_bib0059","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.7150\/thno.42218","article-title":"Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.phymed.2024.155688_bib0060","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.biocel.2009.12.018","article-title":"NFATc1: functions in osteoclasts","volume":"42","author":"Zhao","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"24","key":"10.1016\/j.phymed.2024.155688_sbref0061","article-title":"Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction","volume":"S2090-1232","author":"Zheng","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.phymed.2024.155688_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121611","article-title":"Pogostone attenuates osteolysis in breast cancer by inhibiting the NF-kB and JNK signaling pathways of osteoclast","volume":"328","author":"Zheng","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2024.155688_bib0063","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41401-020-0477-4","article-title":"Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression","volume":"42","author":"Zou","year":"2021","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324003477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324003477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T23:59:52Z","timestamp":1717286392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324003477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":63,"alternative-id":["S0944711324003477"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155688","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155688"}}